Skip to content
Polis

House bill · 89R

HB 3717

Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

Did not pass

Progress

69 days from first to latest action, across 23 recorded actions.

  1. Filed

    Mar 4

  2. Referred to committee

    Mar 26

  3. Heard in committee

    Apr 7

  4. Reported from committee

    Apr 14

  5. Passed first chamber

    Stopped here

  6. Passed second chamber

  7. Sent to governor

  8. Became law

HouseAprMay

Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.

Full history

Every action recorded by Texas Legislature Online.

  1. Laid on the table subject to call

    May 12, 2025 · House

  2. Companion considered in lieu of

    May 12, 2025 · House

  3. Postponed

    May 12, 2025 · House

  4. Laid out as postponed business

    May 12, 2025 · House

  5. Postponed

    May 9, 2025 · House

  6. Laid out as postponed business

    May 9, 2025 · House

  7. Postponed

    May 7, 2025 · House

  8. Laid out as postponed business

    May 7, 2025 · House

  9. Postponed

    May 5, 2025 · House

  10. Read 2nd time

    May 5, 2025 · House

  11. Placed on General State Calendar

    May 2, 2025 · House

  12. Considered in Calendars

    Apr 30, 2025 · House

  13. Committee report sent to Calendars

    Apr 25, 2025 · House

  14. Committee report distributed

    Apr 23, 2025 · House

  15. Comte report filed with Committee Coordinator

    Apr 23, 2025 · House

  16. Reported favorably w/o amendment(s) Public Health

    Apr 14, 2025 · House

  17. Considered in public hearing Public Health

    Apr 14, 2025 · House

  18. Left pending in committee

    Apr 7, 2025 · House

  19. Testimony taken/registration(s) recorded in committee Public Health

    Apr 7, 2025 · House

  20. Considered in public hearing Public Health

    Apr 7, 2025 · House

  21. Referred to Public Health Public Health

    Mar 26, 2025 · House

  22. Read first time

    Mar 26, 2025 · House

  23. Filed

    Mar 4, 2025 · House

Authors

and 29 coauthors or sponsors

Show 29 more
  • Marc LaHood cosponsorR
  • Cody Vasut cosponsorR
  • Josey Garcia cosponsorD
  • Stan Gerdes cosponsorR
  • Mike Olcott cosponsorR
  • Katrina Pierson cosponsorR
  • Valoree Swanson cosponsorR
  • Alan Schoolcraft cosponsorR
  • Janie Lopez cosponsorR
  • Joanne Shofner cosponsorR
  • Will Metcalf cosponsorR
  • Richard Raymond cosponsorD
  • Daniel Alders cosponsorR
  • Aicha Davis cosponsorD
  • Eddie Morales cosponsorD
  • Erin Gámez cosponsorD
  • Erin Zwiener cosponsorD
  • Brad Buckley cosponsorR
  • Don McLaughlin cosponsorR
  • Terri Leo-Wilson cosponsorR
  • Denise Villalobos cosponsorR
  • Tony Tinderholt cosponsorR
  • Suleman Lalani cosponsorD
  • Keith Bell cosponsorR
  • Penny Morales Shaw cosponsorD
  • John Lujan cosponsorR
  • Jeff Barry cosponsorR
  • Cole Hefner cosponsorR
  • Briscoe Cain cosponsorR

In committee

  • Public Health

    House

    Referred Mar 26, 2025 · heard Apr 7, 2025 · reported after 19 days

Topics

Bill text

Bills on similar topics

Other legislation this session sharing the most index topics.

BillAuthorProgressStatusLast action
HB 1837Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1 or 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.Ryan GuillenRPassed first chamberDid not passMay 13, 2025Referred to Criminal Justice
HB 3062Relating to fentanyl prevention and drug poisoning awareness education for students enrolled in public institutions of higher education.Bobby GuerraDBecame lawBecame lawJun 20, 2025Effective immediately
HB 171Relating to the certificate of medical examination for chemical dependency and the duration of court-ordered treatment for a person with a chemical dependency.Ryan GuillenRBecame lawBecame lawJun 20, 2025Effective on 9/1/25
HB 4783Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.Gary VanDeaverRBecame lawBecame lawJun 20, 2025Effective on 9/1/25
SB 1936Relating to the definition of an abuse unit for certain controlled substances under the Texas Controlled Substances Act.Chuy HinojosaDBecame lawBecame lawJun 20, 2025Effective on 9/1/25
SB 3Relating to the regulation of products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and permits; imposing fees; creating criminal offenses; authorizing an administrative penalty.Charles PerryRSent to governorVetoedJun 22, 2025Vetoed by the Governor
HB 3717 (89R) · Polis